Skip to content
healthcare.dev
Get a free key

Good Sense Lansoprazole

NDC 0113-0116, Lansoprazole, tablet, orally disintegrating, delayed release, from L. Perrigo Company.

Product NDC
0113-0116
Status
Listed
Labeler
L. Perrigo Company
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA208025
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0113-0116 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
0113-0116-55001130116553 CARTON in 1 CARTON (0113-0116-55) / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0113-0116 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0113-0116 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0113-0116. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.